Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Steve Pascolo

Showing results (11-20 of 80) with videos related to

Pageof 8
Sort By:
Methods in Molecular Biology (Clifton, N.J.)|December 18, 2016
Generation of Immunostimulating 130 nm Protamine-RNA nanoparticlesMarina Tusup, Steve Pascolo
Journal for Immunotherapy of Cancer|June 12, 2021
Implications of mRNA-based SARS-CoV-2 vaccination for cancer patientsEmanuela Romano, Steve Pascolo, Patrick Ott
World Journal of Clinical Oncology|June 15, 2018
Epitranscriptomics of cancerMarina Tusup, Thomas Kundig, Steve Pascolo
Molecular Therapy : the Journal of the American Society of Gene Therapy|September 26, 2021
Epitranscriptomics modifier pentostatin indirectly triggers Toll-like receptor 3 and can enhance immune infiltration in tumorsMarina Tusup, Thomas M Kündig, Steve Pascolo
Vaccine|April 8, 2011
The form of NY-ESO-1 antigen has an impact on the clinical efficacy of anti-tumor vaccinationIana Parvanova, Lorna Rettig, Alexander Knuth, et al.
International Immunology|September 17, 2008
Mass spectrometric identification of an HLA-A*0201 epitope from Plasmodium falciparum MSP-1Jean-Philippe Carralot, Claudia Lemmel, Stefan Stevanovic, et al.
Immunology Letters|November 17, 2007
Plasmid DNA- and messenger RNA-based anti-cancer vaccinationBenjamin Weide, Claus Garbe, Hans-Georg Rammensee, et al.
Pharmaceutics|July 2, 2021
Protamine-Based Strategies for RNA TransfectionNatalia Teresa Jarzebska, Mark Mellett, Julia Frei, et al.
JID Innovations : Skin Science From Molecules to Population Health|January 3, 2022
Increased Chlormethine-Induced DNA Double-Stranded Breaks in Malignant T Cells from Mycosis Fungoides Skin LesionsYun-Tsan Chang, Desislava Ignatova, Wolfram Hoetzenecker, et al.
Frontiers in Immunology|November 4, 2015
Immunity to Pathogens Taught by Specialized Human Dendritic Cell SubsetsJens Geginat, Giulia Nizzoli, Moira Paroni, et al.
Pageof 8

Showing results (11-20 of 80) with videos related to

Sort By:
Pageof 8
Methods in Molecular Biology (Clifton, N.J.)|December 18, 2016
Generation of Immunostimulating 130 nm Protamine-RNA nanoparticlesMarina Tusup, Steve Pascolo
Journal for Immunotherapy of Cancer|June 12, 2021
Implications of mRNA-based SARS-CoV-2 vaccination for cancer patientsEmanuela Romano, Steve Pascolo, Patrick Ott
World Journal of Clinical Oncology|June 15, 2018
Epitranscriptomics of cancerMarina Tusup, Thomas Kundig, Steve Pascolo
Molecular Therapy : the Journal of the American Society of Gene Therapy|September 26, 2021
Epitranscriptomics modifier pentostatin indirectly triggers Toll-like receptor 3 and can enhance immune infiltration in tumorsMarina Tusup, Thomas M Kündig, Steve Pascolo
Vaccine|April 8, 2011
The form of NY-ESO-1 antigen has an impact on the clinical efficacy of anti-tumor vaccinationIana Parvanova, Lorna Rettig, Alexander Knuth, et al.
International Immunology|September 17, 2008
Mass spectrometric identification of an HLA-A*0201 epitope from Plasmodium falciparum MSP-1Jean-Philippe Carralot, Claudia Lemmel, Stefan Stevanovic, et al.
Immunology Letters|November 17, 2007
Plasmid DNA- and messenger RNA-based anti-cancer vaccinationBenjamin Weide, Claus Garbe, Hans-Georg Rammensee, et al.
Pharmaceutics|July 2, 2021
Protamine-Based Strategies for RNA TransfectionNatalia Teresa Jarzebska, Mark Mellett, Julia Frei, et al.
JID Innovations : Skin Science From Molecules to Population Health|January 3, 2022
Increased Chlormethine-Induced DNA Double-Stranded Breaks in Malignant T Cells from Mycosis Fungoides Skin LesionsYun-Tsan Chang, Desislava Ignatova, Wolfram Hoetzenecker, et al.
Frontiers in Immunology|November 4, 2015
Immunity to Pathogens Taught by Specialized Human Dendritic Cell SubsetsJens Geginat, Giulia Nizzoli, Moira Paroni, et al.
Pageof 8